Albumin Paclitaxel Combined with Intrapleural Infusion of Bevacizumab + Lobaplatin for the Second-Line Treatment of Patients with Non-Squamous Non-Small Cell Lung Cancer

Table 1

Comparison of clinical data between the two groups of patients.

Characteristics	Treatment group (n = 62)	Control group (n = 64)	χ^2
Gender			0.002	0.968
Male	38	39
Female	24	25
Age (years)			0.022	0.881
<60	36	38
≥60	26	26
Stage			0.166	0.920
M1a	49	51
M1b	8	7
M1c	5	6
MPE characteristic			0.001	0.97
Bloody	25	26
Non-bloody	37	38
VEGF expression			0.0003	0.99
High	28	29
Low	34	35
Liquor pleurae pH			0.001	0.97
<7.35	25	26
≥7.35	37	38
Hydrothorax CD4^+/CD8^+ value			0.0004	0.10
High	30	31
Low	32	33